vs
AMREP CORP.（AXR）与BIOLIFE SOLUTIONS INC（BLFS）财务数据对比。点击上方公司名可切换其他公司
BIOLIFE SOLUTIONS INC的季度营收约是AMREP CORP.的1.3倍（$18.8M vs $14.6M），BIOLIFE SOLUTIONS INC净利率更高（58.9% vs 21.6%，领先37.3%），AMREP CORP.同比增速更快（93.8% vs 24.3%），过去两年BIOLIFE SOLUTIONS INC的营收复合增速更高（1.0% vs -13.6%）
AMREP是一家总部位于美国新泽西州普林斯顿的企业，核心业务涵盖房地产与媒体服务领域。公司前身为美国地产石油公司，于1961年正式成立，在相关行业拥有六十余年的发展运营历史。
BIOLIFE SOLUTIONS INC专注于开发生物保存产品及冷链管理解决方案，服务于细胞与基因治疗、生物制药及再生医学领域，产品涵盖低温保存培养基、自动化解冻系统、温度监测工具，为全球相关企业、科研机构及临床实验室提供支持。
AXR vs BLFS — 直观对比
营收规模更大
BLFS
是对方的1.3倍
$14.6M
营收增速更快
AXR
高出69.5%
24.3%
净利率更高
BLFS
高出37.3%
21.6%
两年增速更快
BLFS
近两年复合增速
-13.6%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $14.6M | $18.8M |
| 净利润 | $3.1M | $11.1M |
| 毛利率 | — | — |
| 营业利润率 | 20.6% | 7.2% |
| 净利率 | 21.6% | 58.9% |
| 营收同比 | 93.8% | 24.3% |
| 净利润同比 | 338.9% | -11.1% |
| 每股收益（稀释后） | $0.58 | $0.23 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXRBLFS
| Q1 26 | $14.6M | — | ||
| Q4 25 | $9.4M | $18.8M | ||
| Q3 25 | $17.9M | $28.1M | ||
| Q2 25 | $11.2M | $25.4M | ||
| Q1 25 | $7.5M | $23.9M | ||
| Q4 24 | $11.9M | $15.1M | ||
| Q3 24 | $19.1M | $21.4M | ||
| Q2 24 | $19.5M | $19.7M |
净利润AXRBLFS
| Q1 26 | $3.1M | — | ||
| Q4 25 | $1.2M | $11.1M | ||
| Q3 25 | $4.7M | $621.0K | ||
| Q2 25 | $3.9M | $-15.8M | ||
| Q1 25 | $717.0K | $-448.0K | ||
| Q4 24 | $4.0M | $12.5M | ||
| Q3 24 | $4.1M | $-1.7M | ||
| Q2 24 | $4.1M | $-20.7M |
营业利润率AXRBLFS
| Q1 26 | 20.6% | — | ||
| Q4 25 | 11.9% | 7.2% | ||
| Q3 25 | 34.4% | -0.3% | ||
| Q2 25 | 31.7% | -65.5% | ||
| Q1 25 | 5.7% | -5.1% | ||
| Q4 24 | 26.4% | 3.6% | ||
| Q3 24 | 26.1% | -2.0% | ||
| Q2 24 | 23.9% | -6.6% |
净利率AXRBLFS
| Q1 26 | 21.6% | — | ||
| Q4 25 | 12.8% | 58.9% | ||
| Q3 25 | 26.3% | 2.2% | ||
| Q2 25 | 34.8% | -62.3% | ||
| Q1 25 | 9.5% | -1.9% | ||
| Q4 24 | 33.9% | 82.5% | ||
| Q3 24 | 21.3% | -8.0% | ||
| Q2 24 | 21.2% | -105.1% |
每股收益（稀释后）AXRBLFS
| Q1 26 | $0.58 | — | ||
| Q4 25 | $0.22 | $0.23 | ||
| Q3 25 | $0.87 | $0.01 | ||
| Q2 25 | $0.73 | $-0.33 | ||
| Q1 25 | $0.13 | $-0.01 | ||
| Q4 24 | $0.75 | $0.27 | ||
| Q3 24 | $0.76 | $-0.04 | ||
| Q2 24 | $0.77 | $-0.45 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $50.0M | $33.0M |
| 总债务越低越好 | $21.0K | $5.0M |
| 股东权益账面价值 | $139.4M | $371.9M |
| 总资产 | $143.9M | $405.9M |
| 负债/权益比越低杠杆越低 | 0.00× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资AXRBLFS
| Q1 26 | $50.0M | — | ||
| Q4 25 | $44.6M | $33.0M | ||
| Q3 25 | $48.9M | $29.5M | ||
| Q2 25 | $39.5M | $31.9M | ||
| Q1 25 | $36.9M | $66.9M | ||
| Q4 24 | $40.1M | $91.5M | ||
| Q3 24 | $40.4M | $24.0M | ||
| Q2 24 | $29.7M | $22.0M |
总债务AXRBLFS
| Q1 26 | $21.0K | — | ||
| Q4 25 | $23.0K | $5.0M | ||
| Q3 25 | $25.0K | $7.5M | ||
| Q2 25 | $26.0K | $10.1M | ||
| Q1 25 | $29.0K | $12.9M | ||
| Q4 24 | $32.0K | $15.9M | ||
| Q3 24 | $34.0K | $20.1M | ||
| Q2 24 | $35.0K | $21.1M |
股东权益AXRBLFS
| Q1 26 | $139.4M | — | ||
| Q4 25 | $136.0M | $371.9M | ||
| Q3 25 | $134.7M | $353.7M | ||
| Q2 25 | $130.0M | $347.2M | ||
| Q1 25 | $126.0M | $352.6M | ||
| Q4 24 | $125.1M | $348.9M | ||
| Q3 24 | $122.2M | $325.5M | ||
| Q2 24 | $118.0M | $321.4M |
总资产AXRBLFS
| Q1 26 | $143.9M | — | ||
| Q4 25 | $140.1M | $405.9M | ||
| Q3 25 | $140.7M | $392.1M | ||
| Q2 25 | $133.8M | $387.2M | ||
| Q1 25 | $128.9M | $395.1M | ||
| Q4 24 | $129.1M | $399.5M | ||
| Q3 24 | $127.0M | $381.7M | ||
| Q2 24 | $122.8M | $375.0M |
负债/权益比AXRBLFS
| Q1 26 | 0.00× | — | ||
| Q4 25 | 0.00× | 0.01× | ||
| Q3 25 | 0.00× | 0.02× | ||
| Q2 25 | 0.00× | 0.03× | ||
| Q1 25 | 0.00× | 0.04× | ||
| Q4 24 | 0.00× | 0.05× | ||
| Q3 24 | 0.00× | 0.06× | ||
| Q2 24 | 0.00× | 0.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.4M | $4.9M |
| 自由现金流经营现金流 - 资本支出 | $5.4M | — |
| 自由现金流率自由现金流/营收 | 37.0% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | 1.72× | 0.44× |
| 过去12个月自由现金流最近4个季度 | $20.2M | — |
8季度趋势，按日历期对齐
经营现金流AXRBLFS
| Q1 26 | $5.4M | — | ||
| Q4 25 | $-4.3M | $4.9M | ||
| Q3 25 | $9.5M | $6.1M | ||
| Q2 25 | $10.2M | $7.4M | ||
| Q1 25 | $-3.2M | $1.7M | ||
| Q4 24 | $-182.0K | $1.6M | ||
| Q3 24 | $10.7M | $4.8M | ||
| Q2 24 | $10.7M | $6.5M |
自由现金流AXRBLFS
| Q1 26 | $5.4M | — | ||
| Q4 25 | $-4.3M | — | ||
| Q3 25 | $9.5M | — | ||
| Q2 25 | $9.7M | — | ||
| Q1 25 | $-3.3M | — | ||
| Q4 24 | $-268.0K | — | ||
| Q3 24 | $10.7M | — | ||
| Q2 24 | $10.3M | — |
自由现金流率AXRBLFS
| Q1 26 | 37.0% | — | ||
| Q4 25 | -45.9% | — | ||
| Q3 25 | 53.2% | — | ||
| Q2 25 | 86.4% | — | ||
| Q1 25 | -43.4% | — | ||
| Q4 24 | -2.3% | — | ||
| Q3 24 | 55.8% | — | ||
| Q2 24 | 52.5% | — |
资本支出强度AXRBLFS
| Q1 26 | 0.1% | — | ||
| Q4 25 | 0.6% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 5.2% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 0.7% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 2.3% | — |
现金转化率AXRBLFS
| Q1 26 | 1.72× | — | ||
| Q4 25 | -3.54× | 0.44× | ||
| Q3 25 | 2.03× | 9.83× | ||
| Q2 25 | 2.63× | — | ||
| Q1 25 | -4.51× | — | ||
| Q4 24 | -0.05× | 0.13× | ||
| Q3 24 | 2.63× | — | ||
| Q2 24 | 2.59× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
